GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Intuitive Surgical Inc (NAS:ISRG) » Definitions » Return-on-Tangible-Equity

Intuitive Surgical (Intuitive Surgical) Return-on-Tangible-Equity : 16.45% (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Intuitive Surgical Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Intuitive Surgical's annualized net income for the quarter that ended in Mar. 2024 was $2,180 Mil. Intuitive Surgical's average shareholder tangible equity for the quarter that ended in Mar. 2024 was $13,250 Mil. Therefore, Intuitive Surgical's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 was 16.45%.

The historical rank and industry rank for Intuitive Surgical's Return-on-Tangible-Equity or its related term are showing as below:

ISRG' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 11.95   Med: 15.31   Max: 20.65
Current: 16.3

During the past 13 years, Intuitive Surgical's highest Return-on-Tangible-Equity was 20.65%. The lowest was 11.95%. And the median was 15.31%.

ISRG's Return-on-Tangible-Equity is ranked better than
80.83% of 767 companies
in the Medical Devices & Instruments industry
Industry Median: 2.07 vs ISRG: 16.30

Intuitive Surgical Return-on-Tangible-Equity Historical Data

The historical data trend for Intuitive Surgical's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intuitive Surgical Return-on-Tangible-Equity Chart

Intuitive Surgical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.40 12.36 16.39 11.95 15.26

Intuitive Surgical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.24 15.09 14.07 19.35 16.45

Competitive Comparison of Intuitive Surgical's Return-on-Tangible-Equity

For the Medical Instruments & Supplies subindustry, Intuitive Surgical's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intuitive Surgical's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Intuitive Surgical's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Intuitive Surgical's Return-on-Tangible-Equity falls into.



Intuitive Surgical Return-on-Tangible-Equity Calculation

Intuitive Surgical's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=1798/( (10643.6+12919.8 )/ 2 )
=1798/11781.7
=15.26 %

Intuitive Surgical's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=2179.6/( (12919.8+13580.6)/ 2 )
=2179.6/13250.2
=16.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Intuitive Surgical  (NAS:ISRG) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Intuitive Surgical Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Intuitive Surgical's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Intuitive Surgical (Intuitive Surgical) Business Description

Address
1020 Kifer Road, Sunnyvale, CA, USA, 94086-5304
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,000 da Vinci systems in hospitals worldwide, with nearly 5,000 installations in the U.S. and a growing number in emerging markets.
Executives
Alan J Levy director C/O INTUITIVE SURGICAL INC, 1266 KIFER RD, SUNNYVALE CA 94086
Robert Desantis officer: Executive VP & GM IA&E C/O INTUITIVE SURGICAL, INC., 1020 KIFER ROAD, SUNNYVALE CA 94086
Sreelakshmi Kolli director C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 94131
Gary S Guthart director, officer: President & CEO, other: President & CEO C/O INTUITIVE SURGICAL INC, 1266 KIFER RD, SUNNYVALE CA 94086
Amy L Ladd director INTUITIVE SURGICAL, INC, 1020 KIFER RD, SUNNYVALE CA 94086
Craig H Barratt director
Marshall Mohr officer: SVP & CFO C/O INTUITIVE SURGICAL, INC, 1266 KIFER ROAD, SUNNYVALE CA 94086
Mark J Rubash director
David J. Rosa officer: Sr VP Emerging Procedures & Te 1266 KIFER ROAD, SUNNYVALE CA 94086
Fredrik Widman officer: VP Corporate Controller 1020 KIFER ROAD, 1020 KIFER ROAD, SUNNYVALE CA 94086
Myriam Curet officer: SVP & Chief Medical Officer, other: SVP & Chief Medical Officer 1020 KIFER ROAD, SUNNYVALE CA 94086
Michele Dimartino officer: See Remarks 1020 KIFER ROAD, SUNNYVALE CA 94086
Amal M Johnson director C/O MELLANOX TECHNOLOGIES, INC., 350 OAKMEAD PARKWAY, SUITE 100, SUNNYVALE CA 94085
Gary Loeb officer: General Counsel & CCO 5885 HOLLIS ST., SUITE 100, EMERYVILLE CA 94608
Henry L Charlton officer: Senior Vice President & Chief 1020 KIFER ROAD, 1020 KIFER ROAD, SUNNYVALE CA 94086